0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mycoplasma Diagnostics Devices Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-34C3677
Home | Market Reports | Health| Health Foundations & Medical Research
Global Mycoplasma Diagnostics Devices Market Insights Forecast to 2028
BUY CHAPTERS

Global Mycoplasma Diagnostics Devices Market Research Report 2025

Code: QYRE-Auto-34C3677
Report
January 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mycoplasma Diagnostics Devices Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Mycoplasma Diagnostics Devices Market

Mycoplasma Diagnostics Devices Market

The global market for Mycoplasma Diagnostics Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mycoplasma Diagnostics Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycoplasma Diagnostics Devices.
The Mycoplasma Diagnostics Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mycoplasma Diagnostics Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycoplasma Diagnostics Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mycoplasma Diagnostics Devices Market Report

Report Metric Details
Report Name Mycoplasma Diagnostics Devices Market
CAGR 5%
Segment by Type
  • PCR
  • Immunoassay
  • DNA Staining
  • Microbial Culture Techniques
  • Other
Segment by Application
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Agilent Technologies, Thermo Fisher Scientific, PromoCell GmbH, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Holding, Savyon Diagnostics, Tecan Group, Sartorius Stedim BioOutsource, American Type Culture Collection (ATCC), F Hoffmann-La Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mycoplasma Diagnostics Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mycoplasma Diagnostics Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Mycoplasma Diagnostics Devices Market report?

Ans: The main players in the Mycoplasma Diagnostics Devices Market are Agilent Technologies, Thermo Fisher Scientific, PromoCell GmbH, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Holding, Savyon Diagnostics, Tecan Group, Sartorius Stedim BioOutsource, American Type Culture Collection (ATCC), F Hoffmann-La Roche

What are the Application segmentation covered in the Mycoplasma Diagnostics Devices Market report?

Ans: The Applications covered in the Mycoplasma Diagnostics Devices Market report are Hospitals, Clinics, Diagnostic Laboratories, Other

What are the Type segmentation covered in the Mycoplasma Diagnostics Devices Market report?

Ans: The Types covered in the Mycoplasma Diagnostics Devices Market report are PCR, Immunoassay, DNA Staining, Microbial Culture Techniques, Other

1 Mycoplasma Diagnostics Devices Market Overview
1.1 Product Definition
1.2 Mycoplasma Diagnostics Devices by Type
1.2.1 Global Mycoplasma Diagnostics Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 PCR
1.2.3 Immunoassay
1.2.4 DNA Staining
1.2.5 Microbial Culture Techniques
1.2.6 Other
1.3 Mycoplasma Diagnostics Devices by Application
1.3.1 Global Mycoplasma Diagnostics Devices Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Other
1.4 Global Mycoplasma Diagnostics Devices Market Size Estimates and Forecasts
1.4.1 Global Mycoplasma Diagnostics Devices Revenue 2020-2031
1.4.2 Global Mycoplasma Diagnostics Devices Sales 2020-2031
1.4.3 Global Mycoplasma Diagnostics Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mycoplasma Diagnostics Devices Market Competition by Manufacturers
2.1 Global Mycoplasma Diagnostics Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mycoplasma Diagnostics Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mycoplasma Diagnostics Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mycoplasma Diagnostics Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mycoplasma Diagnostics Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mycoplasma Diagnostics Devices, Product Type & Application
2.7 Global Key Manufacturers of Mycoplasma Diagnostics Devices, Date of Enter into This Industry
2.8 Global Mycoplasma Diagnostics Devices Market Competitive Situation and Trends
2.8.1 Global Mycoplasma Diagnostics Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mycoplasma Diagnostics Devices Players Market Share by Revenue
2.8.3 Global Mycoplasma Diagnostics Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mycoplasma Diagnostics Devices Market Scenario by Region
3.1 Global Mycoplasma Diagnostics Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mycoplasma Diagnostics Devices Sales by Region: 2020-2031
3.2.1 Global Mycoplasma Diagnostics Devices Sales by Region: 2020-2025
3.2.2 Global Mycoplasma Diagnostics Devices Sales by Region: 2026-2031
3.3 Global Mycoplasma Diagnostics Devices Revenue by Region: 2020-2031
3.3.1 Global Mycoplasma Diagnostics Devices Revenue by Region: 2020-2025
3.3.2 Global Mycoplasma Diagnostics Devices Revenue by Region: 2026-2031
3.4 North America Mycoplasma Diagnostics Devices Market Facts & Figures by Country
3.4.1 North America Mycoplasma Diagnostics Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mycoplasma Diagnostics Devices Sales by Country (2020-2031)
3.4.3 North America Mycoplasma Diagnostics Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mycoplasma Diagnostics Devices Market Facts & Figures by Country
3.5.1 Europe Mycoplasma Diagnostics Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mycoplasma Diagnostics Devices Sales by Country (2020-2031)
3.5.3 Europe Mycoplasma Diagnostics Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mycoplasma Diagnostics Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Mycoplasma Diagnostics Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mycoplasma Diagnostics Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Mycoplasma Diagnostics Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mycoplasma Diagnostics Devices Market Facts & Figures by Country
3.7.1 Latin America Mycoplasma Diagnostics Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mycoplasma Diagnostics Devices Sales by Country (2020-2031)
3.7.3 Latin America Mycoplasma Diagnostics Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mycoplasma Diagnostics Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Mycoplasma Diagnostics Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mycoplasma Diagnostics Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mycoplasma Diagnostics Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Mycoplasma Diagnostics Devices Sales by Type (2020-2031)
4.1.1 Global Mycoplasma Diagnostics Devices Sales by Type (2020-2025)
4.1.2 Global Mycoplasma Diagnostics Devices Sales by Type (2026-2031)
4.1.3 Global Mycoplasma Diagnostics Devices Sales Market Share by Type (2020-2031)
4.2 Global Mycoplasma Diagnostics Devices Revenue by Type (2020-2031)
4.2.1 Global Mycoplasma Diagnostics Devices Revenue by Type (2020-2025)
4.2.2 Global Mycoplasma Diagnostics Devices Revenue by Type (2026-2031)
4.2.3 Global Mycoplasma Diagnostics Devices Revenue Market Share by Type (2020-2031)
4.3 Global Mycoplasma Diagnostics Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mycoplasma Diagnostics Devices Sales by Application (2020-2031)
5.1.1 Global Mycoplasma Diagnostics Devices Sales by Application (2020-2025)
5.1.2 Global Mycoplasma Diagnostics Devices Sales by Application (2026-2031)
5.1.3 Global Mycoplasma Diagnostics Devices Sales Market Share by Application (2020-2031)
5.2 Global Mycoplasma Diagnostics Devices Revenue by Application (2020-2031)
5.2.1 Global Mycoplasma Diagnostics Devices Revenue by Application (2020-2025)
5.2.2 Global Mycoplasma Diagnostics Devices Revenue by Application (2026-2031)
5.2.3 Global Mycoplasma Diagnostics Devices Revenue Market Share by Application (2020-2031)
5.3 Global Mycoplasma Diagnostics Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Agilent Technologies
6.1.1 Agilent Technologies Company Information
6.1.2 Agilent Technologies Description and Business Overview
6.1.3 Agilent Technologies Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Agilent Technologies Mycoplasma Diagnostics Devices Product Portfolio
6.1.5 Agilent Technologies Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Scientific Mycoplasma Diagnostics Devices Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 PromoCell GmbH
6.3.1 PromoCell GmbH Company Information
6.3.2 PromoCell GmbH Description and Business Overview
6.3.3 PromoCell GmbH Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 PromoCell GmbH Mycoplasma Diagnostics Devices Product Portfolio
6.3.5 PromoCell GmbH Recent Developments/Updates
6.4 Charles River Laboratories International
6.4.1 Charles River Laboratories International Company Information
6.4.2 Charles River Laboratories International Description and Business Overview
6.4.3 Charles River Laboratories International Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Charles River Laboratories International Mycoplasma Diagnostics Devices Product Portfolio
6.4.5 Charles River Laboratories International Recent Developments/Updates
6.5 Merck KGaA
6.5.1 Merck KGaA Company Information
6.5.2 Merck KGaA Description and Business Overview
6.5.3 Merck KGaA Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck KGaA Mycoplasma Diagnostics Devices Product Portfolio
6.5.5 Merck KGaA Recent Developments/Updates
6.6 Lonza Group
6.6.1 Lonza Group Company Information
6.6.2 Lonza Group Description and Business Overview
6.6.3 Lonza Group Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lonza Group Mycoplasma Diagnostics Devices Product Portfolio
6.6.5 Lonza Group Recent Developments/Updates
6.7 Takara Holding
6.7.1 Takara Holding Company Information
6.7.2 Takara Holding Description and Business Overview
6.7.3 Takara Holding Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Takara Holding Mycoplasma Diagnostics Devices Product Portfolio
6.7.5 Takara Holding Recent Developments/Updates
6.8 Savyon Diagnostics
6.8.1 Savyon Diagnostics Company Information
6.8.2 Savyon Diagnostics Description and Business Overview
6.8.3 Savyon Diagnostics Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Savyon Diagnostics Mycoplasma Diagnostics Devices Product Portfolio
6.8.5 Savyon Diagnostics Recent Developments/Updates
6.9 Tecan Group
6.9.1 Tecan Group Company Information
6.9.2 Tecan Group Description and Business Overview
6.9.3 Tecan Group Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Tecan Group Mycoplasma Diagnostics Devices Product Portfolio
6.9.5 Tecan Group Recent Developments/Updates
6.10 Sartorius Stedim BioOutsource
6.10.1 Sartorius Stedim BioOutsource Company Information
6.10.2 Sartorius Stedim BioOutsource Description and Business Overview
6.10.3 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Devices Product Portfolio
6.10.5 Sartorius Stedim BioOutsource Recent Developments/Updates
6.11 American Type Culture Collection (ATCC)
6.11.1 American Type Culture Collection (ATCC) Company Information
6.11.2 American Type Culture Collection (ATCC) Description and Business Overview
6.11.3 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Devices Product Portfolio
6.11.5 American Type Culture Collection (ATCC) Recent Developments/Updates
6.12 F Hoffmann-La Roche
6.12.1 F Hoffmann-La Roche Company Information
6.12.2 F Hoffmann-La Roche Description and Business Overview
6.12.3 F Hoffmann-La Roche Mycoplasma Diagnostics Devices Sales, Revenue and Gross Margin (2020-2025)
6.12.4 F Hoffmann-La Roche Mycoplasma Diagnostics Devices Product Portfolio
6.12.5 F Hoffmann-La Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mycoplasma Diagnostics Devices Industry Chain Analysis
7.2 Mycoplasma Diagnostics Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mycoplasma Diagnostics Devices Production Mode & Process Analysis
7.4 Mycoplasma Diagnostics Devices Sales and Marketing
7.4.1 Mycoplasma Diagnostics Devices Sales Channels
7.4.2 Mycoplasma Diagnostics Devices Distributors
7.5 Mycoplasma Diagnostics Devices Customer Analysis
8 Mycoplasma Diagnostics Devices Market Dynamics
8.1 Mycoplasma Diagnostics Devices Industry Trends
8.2 Mycoplasma Diagnostics Devices Market Drivers
8.3 Mycoplasma Diagnostics Devices Market Challenges
8.4 Mycoplasma Diagnostics Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Mycoplasma Diagnostics Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Mycoplasma Diagnostics Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Mycoplasma Diagnostics Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Mycoplasma Diagnostics Devices Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Mycoplasma Diagnostics Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Mycoplasma Diagnostics Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Mycoplasma Diagnostics Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Mycoplasma Diagnostics Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Mycoplasma Diagnostics Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mycoplasma Diagnostics Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mycoplasma Diagnostics Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Mycoplasma Diagnostics Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mycoplasma Diagnostics Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Diagnostics Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mycoplasma Diagnostics Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Mycoplasma Diagnostics Devices Sales by Region (2020-2025) & (Units)
 Table 18. Global Mycoplasma Diagnostics Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Mycoplasma Diagnostics Devices Sales by Region (2026-2031) & (Units)
 Table 20. Global Mycoplasma Diagnostics Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Mycoplasma Diagnostics Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Mycoplasma Diagnostics Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Mycoplasma Diagnostics Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Mycoplasma Diagnostics Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Mycoplasma Diagnostics Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Mycoplasma Diagnostics Devices Sales by Country (2020-2025) & (Units)
 Table 27. North America Mycoplasma Diagnostics Devices Sales by Country (2026-2031) & (Units)
 Table 28. North America Mycoplasma Diagnostics Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Mycoplasma Diagnostics Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Mycoplasma Diagnostics Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Mycoplasma Diagnostics Devices Sales by Country (2020-2025) & (Units)
 Table 32. Europe Mycoplasma Diagnostics Devices Sales by Country (2026-2031) & (Units)
 Table 33. Europe Mycoplasma Diagnostics Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Mycoplasma Diagnostics Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Mycoplasma Diagnostics Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Mycoplasma Diagnostics Devices Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Mycoplasma Diagnostics Devices Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Mycoplasma Diagnostics Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Mycoplasma Diagnostics Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Mycoplasma Diagnostics Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Mycoplasma Diagnostics Devices Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Mycoplasma Diagnostics Devices Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Mycoplasma Diagnostics Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Mycoplasma Diagnostics Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Mycoplasma Diagnostics Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Mycoplasma Diagnostics Devices Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Mycoplasma Diagnostics Devices Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Mycoplasma Diagnostics Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Mycoplasma Diagnostics Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Mycoplasma Diagnostics Devices Sales (Units) by Type (2020-2025)
 Table 51. Global Mycoplasma Diagnostics Devices Sales (Units) by Type (2026-2031)
 Table 52. Global Mycoplasma Diagnostics Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Mycoplasma Diagnostics Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Mycoplasma Diagnostics Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Mycoplasma Diagnostics Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Mycoplasma Diagnostics Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Mycoplasma Diagnostics Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Mycoplasma Diagnostics Devices Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Mycoplasma Diagnostics Devices Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Mycoplasma Diagnostics Devices Sales (Units) by Application (2020-2025)
 Table 61. Global Mycoplasma Diagnostics Devices Sales (Units) by Application (2026-2031)
 Table 62. Global Mycoplasma Diagnostics Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Mycoplasma Diagnostics Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Mycoplasma Diagnostics Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Mycoplasma Diagnostics Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Mycoplasma Diagnostics Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Mycoplasma Diagnostics Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Mycoplasma Diagnostics Devices Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Mycoplasma Diagnostics Devices Price (USD/Unit) by Application (2026-2031)
 Table 70. Agilent Technologies Company Information
 Table 71. Agilent Technologies Description and Business Overview
 Table 72. Agilent Technologies Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Agilent Technologies Mycoplasma Diagnostics Devices Product
 Table 74. Agilent Technologies Recent Developments/Updates
 Table 75. Thermo Fisher Scientific Company Information
 Table 76. Thermo Fisher Scientific Description and Business Overview
 Table 77. Thermo Fisher Scientific Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Thermo Fisher Scientific Mycoplasma Diagnostics Devices Product
 Table 79. Thermo Fisher Scientific Recent Developments/Updates
 Table 80. PromoCell GmbH Company Information
 Table 81. PromoCell GmbH Description and Business Overview
 Table 82. PromoCell GmbH Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. PromoCell GmbH Mycoplasma Diagnostics Devices Product
 Table 84. PromoCell GmbH Recent Developments/Updates
 Table 85. Charles River Laboratories International Company Information
 Table 86. Charles River Laboratories International Description and Business Overview
 Table 87. Charles River Laboratories International Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Charles River Laboratories International Mycoplasma Diagnostics Devices Product
 Table 89. Charles River Laboratories International Recent Developments/Updates
 Table 90. Merck KGaA Company Information
 Table 91. Merck KGaA Description and Business Overview
 Table 92. Merck KGaA Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Merck KGaA Mycoplasma Diagnostics Devices Product
 Table 94. Merck KGaA Recent Developments/Updates
 Table 95. Lonza Group Company Information
 Table 96. Lonza Group Description and Business Overview
 Table 97. Lonza Group Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Lonza Group Mycoplasma Diagnostics Devices Product
 Table 99. Lonza Group Recent Developments/Updates
 Table 100. Takara Holding Company Information
 Table 101. Takara Holding Description and Business Overview
 Table 102. Takara Holding Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Takara Holding Mycoplasma Diagnostics Devices Product
 Table 104. Takara Holding Recent Developments/Updates
 Table 105. Savyon Diagnostics Company Information
 Table 106. Savyon Diagnostics Description and Business Overview
 Table 107. Savyon Diagnostics Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Savyon Diagnostics Mycoplasma Diagnostics Devices Product
 Table 109. Savyon Diagnostics Recent Developments/Updates
 Table 110. Tecan Group Company Information
 Table 111. Tecan Group Description and Business Overview
 Table 112. Tecan Group Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Tecan Group Mycoplasma Diagnostics Devices Product
 Table 114. Tecan Group Recent Developments/Updates
 Table 115. Sartorius Stedim BioOutsource Company Information
 Table 116. Sartorius Stedim BioOutsource Description and Business Overview
 Table 117. Sartorius Stedim BioOutsource Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Sartorius Stedim BioOutsource Mycoplasma Diagnostics Devices Product
 Table 119. Sartorius Stedim BioOutsource Recent Developments/Updates
 Table 120. American Type Culture Collection (ATCC) Company Information
 Table 121. American Type Culture Collection (ATCC) Description and Business Overview
 Table 122. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Devices Product
 Table 124. American Type Culture Collection (ATCC) Recent Developments/Updates
 Table 125. F Hoffmann-La Roche Company Information
 Table 126. F Hoffmann-La Roche Description and Business Overview
 Table 127. F Hoffmann-La Roche Mycoplasma Diagnostics Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. F Hoffmann-La Roche Mycoplasma Diagnostics Devices Product
 Table 129. F Hoffmann-La Roche Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Mycoplasma Diagnostics Devices Distributors List
 Table 133. Mycoplasma Diagnostics Devices Customers List
 Table 134. Mycoplasma Diagnostics Devices Market Trends
 Table 135. Mycoplasma Diagnostics Devices Market Drivers
 Table 136. Mycoplasma Diagnostics Devices Market Challenges
 Table 137. Mycoplasma Diagnostics Devices Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mycoplasma Diagnostics Devices
 Figure 2. Global Mycoplasma Diagnostics Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Mycoplasma Diagnostics Devices Market Share by Type: 2024 & 2031
 Figure 4. PCR Product Picture
 Figure 5. Immunoassay Product Picture
 Figure 6. DNA Staining Product Picture
 Figure 7. Microbial Culture Techniques Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Mycoplasma Diagnostics Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Mycoplasma Diagnostics Devices Market Share by Application: 2024 & 2031
 Figure 11. Hospitals
 Figure 12. Clinics
 Figure 13. Diagnostic Laboratories
 Figure 14. Other
 Figure 15. Global Mycoplasma Diagnostics Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Mycoplasma Diagnostics Devices Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Mycoplasma Diagnostics Devices Sales (2020-2031) & (Units)
 Figure 18. Global Mycoplasma Diagnostics Devices Average Price (USD/Unit) & (2020-2031)
 Figure 19. Mycoplasma Diagnostics Devices Report Years Considered
 Figure 20. Mycoplasma Diagnostics Devices Sales Share by Manufacturers in 2024
 Figure 21. Global Mycoplasma Diagnostics Devices Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Mycoplasma Diagnostics Devices Players: Market Share by Revenue in Mycoplasma Diagnostics Devices in 2024
 Figure 23. Mycoplasma Diagnostics Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Mycoplasma Diagnostics Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Mycoplasma Diagnostics Devices Sales Market Share by Country (2020-2031)
 Figure 26. North America Mycoplasma Diagnostics Devices Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Mycoplasma Diagnostics Devices Sales Market Share by Country (2020-2031)
 Figure 30. Europe Mycoplasma Diagnostics Devices Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Mycoplasma Diagnostics Devices Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Mycoplasma Diagnostics Devices Revenue Market Share by Region (2020-2031)
 Figure 38. China Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Mycoplasma Diagnostics Devices Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Mycoplasma Diagnostics Devices Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Mycoplasma Diagnostics Devices Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Mycoplasma Diagnostics Devices Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. U.A.E Mycoplasma Diagnostics Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Mycoplasma Diagnostics Devices by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Mycoplasma Diagnostics Devices by Type (2020-2031)
 Figure 60. Global Mycoplasma Diagnostics Devices Price (USD/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Mycoplasma Diagnostics Devices by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Mycoplasma Diagnostics Devices by Application (2020-2031)
 Figure 63. Global Mycoplasma Diagnostics Devices Price (USD/Unit) by Application (2020-2031)
 Figure 64. Mycoplasma Diagnostics Devices Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Liraglutide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-29O4198
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Mesenchymal Stem Cell Medium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10X13372
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Vascular Endothelial Growth Factor Detection Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7D19343
Fri Mar 14 00:00:00 UTC 2025

Add to Cart

Global Clinical Digital Pathology Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33F15637
Thu Mar 13 00:00:00 UTC 2025

Add to Cart